Los Angeles Capital Management LLC Selecta Biosciences Inc Transaction History

Los Angeles Capital Management LLC

  • $24.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$0.67 - $1.4 $133,299 - $278,537
-198,955 Closed
0 $0
Q1 2022

May 06, 2022
SELL
$1.23 - $3.31 $15,568 - $41,894
-12,657 Reduced 5.98%
198,955 $245,000
Q4 2021

Feb 03, 2022
BUY
$2.89 - $4.43 $557,697 - $854,879
192,975 Added 1035.44%
211,612 $690,000
Q3 2021

Nov 08, 2021
BUY
$3.36 - $4.62 $26,409 - $36,313
7,860 Added 72.93%
18,637 $78,000
Q2 2021

Aug 05, 2021
BUY
$2.82 - $5.01 $30,391 - $53,992
10,777 New
10,777 $45,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email